Home \ Library - Page 8

Library - Page 8

Registered on ClinicalTrials

Results of an international multicenter, randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of sequential therapy with ethylmethylhydroxypyridine succinate in patients in the acute and early recovery periods of ischemic stroke (IS)

The results of a cohort -center randomized study of the modulating effect of Mexidol® in the rehabilitation of patients who have undergone acute cerebral failure

The value of mitochondrial dysfunction in stabilization

The results of a multicenter dual blind randomized placebo-controlled clinical study on the assessment of the effectiveness and safety of the drug Mexidol in the treatment of attention deficit syndrome in children (mega)

The results of an international multicenter randomized double-blind-controlled study of evaluating the effectiveness of the effectiveness and safety of consistent therapy of patients with chronic brain ischemia with Mexidol and Mexidol Forte 250 (study of Memo)

The results of a randomized double blind multicenter placebo-controlled in parallel groups of the study and safety of Mexidol with prolonged consistent therapy in patients in the acute and early recovery periods

The results of a cohort -center randomized study of the modulating effect of Mexidol® in the rehabilitation of patients who have undergone acute cerebral failure

The value of mitochondrial dysfunction in stabilization

Pharmacoeconomic analysis of neuroprotectors used in the treatment of ischemic stroke

Authors:
R.I. YAGUDINA¹, A.Yu. KULIKOV¹, V.A. KRYLOV¹, E.Yu. SOLOVYEVA², A.I. FEDIN²

¹Federal State Budgetary Institution of Higher Education “I.M. Sechenov First Moscow State Medical University” of the Russian Ministry of Health (Sechenov University), Moscow, Russia;
²Federal State Budgetary Institution of Higher Education “N.I. Pirogov Russian National Research Medical University” of the Russian Ministry of Health, Moscow, Russia

Modern ideas about the antihypoxic and antioxidant effects of Mexidol

Author:
A.V. SHCHULKIN

Results of a Randomized, Double-Blind, Multicenter, Placebo-Controlled, Parallel-Group Study of the Effi Cace and Safety of Mexidol in Prolonged Sequential Therapy of Patient S in the Acute and Early Recovery Stages of Hemisphereic Stroke (The Epica Study)

Authors:

LV Stakhovskaya¹, NA Shamalov¹, DR Khasanova², EV Melnikova³, AS Agafina⁴, KV Golikov⁵, EI Bogdanov⁶, AA Yakupova⁶, LV Roshkovskaya⁷, LV Lukinykh⁸, TM Lokshtanova⁹, IE Poverennova¹⁰, LA Shchepankevich¹¹

^1ResearchInstitute of Cerebrovascular Pathology and Stroke, Pirogov Russian National Research Medical University, Russian Ministry of Health, Moscow, Russia.
²Interregional Clinical Diagnostic Center, Kazan, Russia.
³St. Petersburg City Clinical Hospital No. 26, St. Petersburg, Russia.
⁴St. Petersburg City Clinical Hospital No. 40 of the Resort Administrative District, St. Petersburg, Russia.
⁵St. Petersburg City General Hospital No. 2, St. Petersburg, Russia.
⁶Kazan Sate Medical University, Russian Ministry of Health, Kazan, Russia.
⁷Nikolaevskaya Hospital, St. Petersburg, Russia.
⁸Vsevolzhsk Clinical Interregional Hospital, Leningradskaya Oblast, Russia.
⁹Pirogov City Clinical Hospital No. 1, Samara, Russia.
¹⁰Seredavin Samara Regional Clinical Hospital, Samara, Russia.
¹¹Research Institute of Experimental and Clinical Medicine, Novosibirsk, Russia.

Publication place:
NEUROSCIENCE AND BEHAVIORAL PHYSIOLOGY, VOL. 48, NO. 8, OCTOBER, 2018

Vegetative dysfunction in patients with cerebrovascular diseases and metabolic syndrome

Author:
V.N. SHISHKOVA
, Federal State Budgetary Institution National Medical Research Center for Therapeutic and Preventive Medicine, Ministry of Health of the Russian Federation, Moscow, Russia

The results of a cohort -center randomized study of the modulating effect of Mexidol® in the rehabilitation of patients who have undergone acute cerebral failure

Registered on ClinicalTrials

A.A. BELKIN, V.A. BELKIN, I.E. VASILCENKO, E.A. PINCHUK
ANO "Clinical Institute of the Brain", Sverdlovsk region, Berezovsky, Russia

Link to the study here

Place of publication:
S.S. KORSAKOV JOURNAL OF NEUROLOGY AND PSYCHIATRY, 2024, Vol. 124, No. 4

The effectiveness of the use of Mexidol in combination with revascularization of the brain in the treatment of ischemic stroke

Authors:
A.M. ALASHEEV¹, E.V. LANTSOVA²¹State Healthcare Institution of the Sverdlovsk Region “Sverdlovsk Regional Clinical Hospital No. 1”, Yekaterinburg, Russia;
²OOO “Sciencefiles”, Yekaterinburg, Russia

Pharmacological correction of the cognitive status of patients with post -shoe syndrome

Author:
L. V. CHICHANOVSKAYA, T. A. SLYUSAR, Yu. V. ABRAMENKO, T. M. NEKRASOVA, I. N. SLYUSAR

FSBEI in the Tver State Medical University of the Ministry of Health of Russia, Tver

The effectiveness of Mexidol Correction in the correction of the post -shoe syndrome in patients with chronic cerebrovascular diseases

Authors:

E.B. Kuznetsova, E.A. Salina, N.S. Kuznetsov

FSBEI in "Saratov State Medical University named after V.I. Razumovsky "Ministry of Health of Russia, Saratov, Russia

Clinical and psychological profile and quality of life of patients with post-shoe syndrome

Authors:
L. V. CHICHANOVSKAYA, T. A. SLYUSAR, Yu. V. ABRAMENKO, T. M. NEKRASOVA, I. N. SLYUSAR

FSBEI in the Tver State Medical University of the Ministry of Health of Russia, Tver, Russia

Features of the treatment and rehabilitation of patients who suffered Covid-19 with ischemic stroke

Authors:
G.S. RAHIMBAEVA, S.R. GAZIEVA, M.K. ATANIYAZOV, F.Kh. MURATOV, D.S. TOLIPOV, U.D. SHODIEV

Tashkent Medical Academy, Tashkent, Republic of Uzbekistan

Neurological manifestations of post -shoe syndrome

Authors:

P.R. KAMCHATNOV¹, R.A. CHEREMIN², L.A. SKIPETROVA², A.V. CHUGUNOV¹

¹Federal State Budgetary Educational Institution of Higher Education “N.I. Pirogov Russian National Research Medical University” of the Ministry of Health of the Russian Federation, Moscow, Russia;
²State Budgetary Healthcare Institution “Speech Pathology and Neurorehabilitation Center of the Moscow Department of Health”, Moscow, Russia.

Frequent neurological symptoms of Long-Covid and their correction paths

Author

Ostroumova T.M. - Ph.D., assistant department of the department of nervous diseases and neurosurgery of the Institute of Clinical Medicine named after N.V. Sklifosovsky FGAOU in the First MGMU named after THEM. Sechenova of the Ministry of Health of Russia (Sechenov University)

Place of publication:

03.2022

The use of Mexidol in patients with chemical and covid-19

Author:
A.I. FEDIN

FGAOU in Russian National Research Medical University named after N.I. Pirogov »Ministry of Health of Russia, Moscow, Russia

Asthenia and cognitive disorders against the background of the transformed infections of the Covid-19: possible correction routes

Author:
OSTROUMOVA T.M.

FGAOU in "First Moscow State Medical University named after THEM. Sechenov "Ministry of Health of Russia (Sechenov University), Moscow, Russia

The possibilities of increasing the effectiveness of patients with chronic brain ischemia against the background of Covid-19

Authors:
V.V. KOVALCHUK, I.I. ERSHOVA, N.V. MOLODOVSKAYA

St. Petersburg GBUZ "City Hospital No. 38 named after N.A. Semashko ", St. Petersburg, Russia

The role of antioxidant therapy in patients with the new coronavirus infection of the Covid-19 of the Motenza and Severe

Authors:
E.K. SHAVAROVA^1,2, E.R. KAZAKHMEDOV¹, M.V. ALEXEEVA¹, L.G. EZHOVA², Zh.D. KOBALAVA¹

¹Peoples' Friendship University of Russia (RUDN University), Moscow, Russian Federation;
²Vinogradov City Clinical Hospital, Moscow Department of Health, Moscow, Russian Federation

« 1 … 6 7 8 9 10 … 14 »

THE INFORMATION IS INTENDED FOR HEALTHCARE AND PHARMACEUTICAL PROFESSIONALS. THIS INFORMATION IS NOT INTENDED AS A SUBSTITUTE FOR MEDICAL ADVICE.

Source of photos and images Shutterstock.com